AKT1 and cancer: According to Qiao et al., GRPR inhibition reduced the expression of important regulators of protein synthesis and cell metabolism by reducing the PI3K/Akt/mTOR pathway, which is typically associated with the promotion of aerobic glycolysis in cancer cells [346].